Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- NOSE-400Independent statistical analysis of A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NOTESIndependent statistical analysis of Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Novel Airway Device to Aid Endotracheal Intubations: Complete Statistical AnalysisIndependent statistical analysis of Novel Airway Device to Aid Endotracheal Intubations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03340207).
- Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE): Complete Statistical AnalysisIndependent statistical analysis of Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Novel Management of Airway Protection in Parkinson’s Disease: A Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study: Complete Statistical AnalysisIndependent statistical analysis of Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05371509).
- Novel Treatment of Comorbid Insomnia and Sleep Apnea in Older Veterans: Complete Statistical AnalysisIndependent statistical analysis of Novel Treatment of Comorbid Insomnia and Sleep Apnea in Older Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Novel Use of an Enhanced Fluoroscopic Imaging Device to Reduce Radiation Exposure and Operative Time During Intramedullary Nailing of Hip Fractures: Complete Statistical AnalysisIndependent statistical analysis of Novel Use of an Enhanced Fluoroscopic Imaging Device to Reduce Radiation Exposure and Operative Time During Intramedullary Nailing of Hip Fractures: primary endpoint results, effect estimate with confidence…
- NOVELAIndependent statistical analysis of Improving Self-Efficacy Through a Telenovela: Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04533594).
- nPower™-USIndependent statistical analysis of Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies: Complete Statistical AnalysisIndependent statistical analysis of NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NPWTCSIndependent statistical analysis of Negative Pressure Wound Therapy in Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02289157).
- NR in Chemo-induced Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of NR in Chemo-induced Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642990).
- NRRIndependent statistical analysis of Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- NRRIndependent statistical analysis of Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NSCLCIndependent statistical analysis of Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- NSCLCIndependent statistical analysis of Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00673049).
- NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: Complete Statistical AnalysisIndependent statistical analysis of NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NT-I7 for Kaposi Sarcoma in Patients With or Without HIV: Complete Statistical AnalysisIndependent statistical analysis of NT-I7 for Kaposi Sarcoma in Patients With or Without HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04893018).
- NTXIndependent statistical analysis of Naltrexone for Antipsychotic-Induced Weight Gain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01866098).
- NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NU-DSMPIndependent statistical analysis of Pilot Trial of the Nutrition-Supported Diabetes Education Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05067452).
- NUCALA® Special Drug Use Investigation (EGPA, Long-term): Complete Statistical AnalysisIndependent statistical analysis of NUCALA® Special Drug Use Investigation (EGPA, Long-term): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03557060).
- NUDGE-EHRIndependent statistical analysis of Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Nudges and Incentives to Enhance the Opioid Treatment Workforce: Complete Statistical AnalysisIndependent statistical analysis of Nudges and Incentives to Enhance the Opioid Treatment Workforce: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03834025).
- Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT: Complete Statistical AnalysisIndependent statistical analysis of Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT: primary endpoint results, effect estimate with confidence interval, sample-size…
- Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab: Complete Statistical AnalysisIndependent statistical analysis of Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01435265).
- Nurse Initiated Acupressure for Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Nurse Initiated Acupressure for Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04044716).
- NURTURE 1Independent statistical analysis of Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis…
- Nutraceutical Efficacy for rUTI: Complete Statistical AnalysisIndependent statistical analysis of Nutraceutical Efficacy for rUTI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395288).
- Nutricity: An mHealth Nutrition Intervention to Improve Diet Quality Among Latino Children: Complete Statistical AnalysisIndependent statistical analysis of Nutricity: An mHealth Nutrition Intervention to Improve Diet Quality Among Latino Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nutrition Monitoring and Feeding Optimization With the smART+ System – Comparative Study: Complete Statistical AnalysisIndependent statistical analysis of Nutrition Monitoring and Feeding Optimization With the smART+ System - Comparative Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nutritional Education and the Prevention of Iron Depletion in Children 9 Months to 2 Years: Complete Statistical AnalysisIndependent statistical analysis of Nutritional Education and the Prevention of Iron Depletion in Children 9 Months to 2 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine: Complete Statistical AnalysisIndependent statistical analysis of NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00199849).
- O-BMTIndependent statistical analysis of Onsite Buprenorphine Treatment at Syringe Exchange Programs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03150173).
- OA CAREIndependent statistical analysis of OA Clinic-Community CARE Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05349500).
- OA-PCPIndependent statistical analysis of Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OAKIndependent statistical analysis of Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- OASISIndependent statistical analysis of Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04720664).
- OASISIndependent statistical analysis of Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- OASISIndependent statistical analysis of BlueWind RENOVA iStim™ System for the Treatment of OAB: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03596671).
- OASISIndependent statistical analysis of Global Sinus Surgery Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02347943).
- OASIS 2Independent statistical analysis of Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity: primary endpoint results, effect estimate…
- OASIS Wound Matrix (Oasis) Mechanism of Action: Complete Statistical AnalysisIndependent statistical analysis of OASIS Wound Matrix (Oasis) Mechanism of Action: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00570141).
- OASIS(CM)Independent statistical analysis of Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OATIndependent statistical analysis of Oral Anticoagulation Therapy Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01959425).
- Obatoclax for Systemic Mastocytosis: Complete Statistical AnalysisIndependent statistical analysis of Obatoclax for Systemic Mastocytosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00918931).
- Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval,…
- ObePso-SIndependent statistical analysis of Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients: primary endpoint results, effect estimate with confidence interval, sample-size…